#USA #New York #Class Action #Securities Fraud #Hims & Hers

Class Action Lawsuit Against Hims & Hers Health, Inc.

On July 25, 2025, Levi & Korsinsky, LLP signaled a significant move by notifying investors in Hims & Hers Health, Inc., listed on the New York Stock Exchange as HIMS, regarding a newly filed class action lawsuit. This lawsuit aims to recover losses for shareholders adversely affected by alleged securities fraud that occurred between April 29, 2025, and June 23, 2025. Investors are invited to act swiftly as the deadline for appointing a lead plaintiff is August 25, 2025.

Background of the Allegations

The crux of the lawsuit is the assertion that the executives at Hims & Hers Health made detrimental false statements and concealed vital information that put its investors at risk. The allegations revolve around the promotion and sale of unauthorized and potentially harmful versions of the weight-loss drug Wegovy®, which raised severe safety concerns for patients. Furthermore, these actions jeopardized the company's collaboration with well-known pharmaceutical group Novo Nordisk.

Hims & Hers Health has been under scrutiny for its marketing practices, and these allegations add to a growing list of concerns that investors have regarding the integrity of the company's operations. The legal complaint states that due to these misleading statements about the business's reliability and future potential, investors were unable to make informed decisions, leading to significant financial losses when the company eventually disclosed the truth.

What's Next for Affected Investors?

If you believe you may have sustained financial losses during the specified time frame, you can partake in this class action lawsuit without bearing any upfront costs. Levi & Korsinsky assures that there will be no out-of-pocket expenses for investors wishing to join this legal initiative. The firm indicates a strong history of winning complex securities litigation, having recovered hundreds of millions of dollars for investors through similar cases in the past two decades.

Joseph E. Levi, one of the founding partners, emphasizes that investors do not need to serve as lead plaintiffs to benefit from any potential recovery resulting from the lawsuit. This aspect may encourage many to step forward, knowing their participation is not contingent on a leading role in the suit.

Levi & Korsinsky's Proven Track Record

Levi & Korsinsky is recognized as one of the top litigation firms in the United States by ISS Securities Class Action Services, having maintained a rank in the top 50 for several consecutive years. The firm boasts a dedicated team of over 70 members specializing in advocating for shareholder rights in securities litigation.

For those interested in joining the lawsuit, they can do so by filling out a form available through a link provided by the firm or by contacting them directly via email or telephone. The firm provides a straightforward approach to assist class members in navigating this process.

Conclusion

The unfolding situation at Hims & Hers Health, Inc. serves as a stark reminder of the risks associated with investing, particularly in companies that undergo rapid expansion and innovation. While the lawsuited may seem daunting, they also provide a path for affected investors to possibly reclaim their losses as legal proceedings move forward. Interested individuals should act promptly to ensure their rights are protected and their voices are heard in this significant case against alleged corporate misconduct.